Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – William Blair issued their Q2 2017 earnings estimates for shares of Acadia Healthcare in a report released on Tuesday. William Blair analyst R. Daniels expects that the company will earn $0.64 per share for the quarter. William Blair currently has a “Outperform” rating on the stock. William Blair also issued estimates for Acadia Healthcare’s Q3 2017 earnings at $0.67 EPS, Q4 2017 earnings at $0.67 EPS, FY2017 earnings at $2.44 EPS, FY2018 earnings at $2.82 EPS and FY2019 earnings at $3.11 EPS.
Several other analysts have also recently commented on the stock. Deutsche Bank AG started coverage on shares of Acadia Healthcare in a research report on Wednesday, April 5th. They set a “buy” rating and a $53.00 target price for the company. Leerink Swann cut shares of Acadia Healthcare from an “outperform” rating to a “market perform” rating in a research report on Monday, May 15th. Zacks Investment Research upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Friday, March 24th. Jefferies Group LLC set a $55.00 target price on shares of Acadia Healthcare and gave the company a “buy” rating in a research report on Thursday, June 1st. Finally, Cantor Fitzgerald reiterated a “hold” rating and set a $45.00 target price on shares of Acadia Healthcare in a research report on Friday, March 24th. Three equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and two have issued a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $57.23.
WARNING: This piece was first published by BBNS and is the property of of BBNS. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be accessed at https://baseballnewssource.com/markets/research-analysts-offer-predictions-for-acadia-healthcare-company-inc-s-q2-2017-earnings-nasdaqachc-updated-updated/1251975.html.
Shares of Acadia Healthcare (NASDAQ ACHC) opened at 50.89 on Thursday. The stock’s 50 day moving average price is $47.24 and its 200 day moving average price is $43.11. Acadia Healthcare has a 1-year low of $32.54 and a 1-year high of $57.29. The company has a market capitalization of $4.47 billion, a price-to-earnings ratio of 295.87 and a beta of 1.14.
Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Tuesday, April 25th. The company reported $0.46 earnings per share for the quarter, hitting the consensus estimate of $0.46. The business had revenue of $679.20 million during the quarter, compared to analyst estimates of $691.74 million. Acadia Healthcare had a return on equity of 8.89% and a net margin of 0.53%. The company’s revenue was up 10.1% compared to the same quarter last year. During the same period last year, the company posted $0.55 EPS.
In other news, VP Randall P. Goldberg sold 4,925 shares of the business’s stock in a transaction on Thursday, May 4th. The shares were sold at an average price of $45.18, for a total value of $222,511.50. Following the completion of the transaction, the vice president now owns 10,607 shares of the company’s stock, valued at approximately $479,224.26. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO Ronald Morgan Fincher sold 86,483 shares of the business’s stock in a transaction on Monday, May 1st. The shares were sold at an average price of $44.43, for a total transaction of $3,842,439.69. Following the completion of the transaction, the chief operating officer now directly owns 137,204 shares of the company’s stock, valued at approximately $6,095,973.72. The disclosure for this sale can be found here. Insiders sold a total of 968,102 shares of company stock valued at $44,283,109 in the last three months. 11.10% of the stock is owned by company insiders.
Institutional investors have recently made changes to their positions in the stock. Nationwide Fund Advisors raised its position in shares of Acadia Healthcare by 683.9% in the first quarter. Nationwide Fund Advisors now owns 75,852 shares of the company’s stock worth $3,307,000 after buying an additional 66,176 shares during the last quarter. Parametrica Management Ltd bought a new position in shares of Acadia Healthcare during the first quarter worth $291,000. Sheets Smith Wealth Management bought a new position in shares of Acadia Healthcare during the first quarter worth $357,000. Peregrine Capital Management LLC bought a new position in shares of Acadia Healthcare during the first quarter worth $9,782,000. Finally, Macquarie Group Ltd. raised its position in shares of Acadia Healthcare by 172.2% in the fourth quarter. Macquarie Group Ltd. now owns 83,280 shares of the company’s stock worth $2,757,000 after buying an additional 52,690 shares during the last quarter.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with our FREE daily email newsletter.